Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Alan Sandler
Person

Alan Sandler

Tracked across 1 events · 10 articles · First seen Apr 19, 2026 · Last active Apr 19, 2026

Sentiment
50
Attention
4
Events
1
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 50
Tech
Revolution Medicines Zoldonrasib Phase 1 Data
Alan Sandler, Chief Development Officer of Revolution Medicines, expressed confidence in zoldonrasib's potential as a targeted therapy, indicating the company's strategic direction for advancing the drug.
Apr 19, 2026 · 10 articles
Key Actions (1)
70 Alan Sandler expressed confidence in zoldonrasib's potential as targeted therapyRevolution Medicines...
Relationships (1)
Revolution Medicines chief development officer ↔ Alan Sandler Alan Sandler is the chief development officer of Revolution Medicines.
NEWSDESK
Track Alan Sandler live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.